Clive Bates , Counterfactual Consulting, United Kingdom. Clive Bates has had varied career having worked in the private sector for IBM, in the UK government in Tony Blair's Strategy Unit, the United Nations in Sudan, for Greenpeace and for Action on Smoking and Health in the UK, which is why he is interested in smoke free alternatives to tobacco. Since early 2013 he has his own public interest consultancy and advocacy organisation, including the Counterfactual blog. He is interested in the enormous public health potential of tobacco harm reduction and is not engaged by pharmaceutical, e-cigarette or tobacco interests.
Linda Bauld is Professor of Health Policy, Director of the Institute for Social Marketing and Dean of Research at the University of Stirling in the UK. She is also Deputy Director of the UK Centre for Tobacco and Alcohol Studies, a UKCRC Centre for Excellence that covers 13 Universities, and holds the CRUK/BUPA Chair in Behavioural Research for Cancer Prevention at Cancer Research UK. Her main research interests are in smoking cessation, tobacco control and alcohol policy with current studies focusing on tobacco and alcohol use in pregnancy and on tobacco harm reduction in particular. She is a former scientific adviser on tobacco control to the UK government and is a member of a number of public health advisory and funding committees in Scotland and England.
Peter Beckett is a consultant who specialises in the identification, analysis and management of political risk. He spent nearly three years as Head of Public Policy for ECITA, where he was responsible for industry-level political advocacy during the procedure that led to the passage of the Tobacco Products Directive. He has also been instrumental in its implementation, is an expert in compliance with its requirements and was at the centre of negotiations that led to the formation of CEN TC 437 on electronic cigarettes and e-liquids. He has worked and consulted for a rangeof leading vapour companies in the EU and US.
Atakan Erik Befrits is a Turkish/Swedish THR advocate, policy researcher and Harm Reduction entrepreneur
Mr Befrits works for global recognition and adoption of Tobacco Harm Reduction as a vital and crucial tool for better Public Health and argues that this strategy is clearly stipulated as mandatory in the FCTC. Atakan is an economist and business manager with a solid background in PR, Management, NGO fundraising, entrepreneurship, HACCP, foodstuffs production and retail. Atakan is backed by a solid team of professionals from the Pharmaceutical Industry, Human Rights Law, the Sciences of Health Economics and medicine. Mr Befrits primary area of advocacy is to internationally provide information on food grade smokeless tobacco (aka snus or snus-analog products) being viable, affordable and 98% harm reduced alternatives to smoking.
John Boley has a background in journalism. An experienced TV/video presenter, producer and writer, he has worked on a wide range of contentious issues, including vehicle emissions and sustainability in Asia's tourism industry. Based in Asia for 20 years, he co-founded factasia.org with Heneage Mitchell in 2012 as both saw issues increasingly misrepresented and consumer rights trampled on.
Dr. Brian Carter is the Director of Scientific Communications for the Consumer Advocates for Smoke-free Alternatives (CASAA). Trained as a clinical psychologist, Dr. Carter’s field of study is addictive behavior, with a focus on the pharmacological, psychological, and behavioral foundations of tobacco and nicotine use, dependence, and motivation. As a faculty member in the Department of Behavioral Science at the University of Texas M.D. Anderson Cancer Center, he conducted multiple National Cancer Institute funded laboratory studies on nicotine use in cigarette smokers. He has widely published his findings in academic journals and has presented at numerous national and international scientific conferences.
Jeannie Cameron is founder and managing director of JCIC International; a UK based strategic advocacy and public affairs consultancy working internationally on various policy areas and specializing in anti-illicit trade, track and trace, supply-chain security, and tobacco harm reduction. She is most well known for being a specialist on the FCTC having attended all its international negotiation sessions, almost all its COPs. Jeannie is experienced in Asia and in Africa and is currently leading an advocacy campaign in the UK to bring about free and fair elections in the Democratic Republic of Congo in line with Security Council resolutions. Jeannie is Co-Chair of the OECD’s Charting Illicit Trade Taskforce on Environmentally Sensitive Goods and Wildlife. Jeannie takes part in various conferences and policy discussions and is known for speaking on these issues candidly.
Cameron worked at BAT between 2001 and 2011 as International Regulatory Affairs Manager and Head of International Advocacy, responsible for policy advice to the BAT group worldwide. Jeannie has an LLM in International Law from Kings College, University of London having received a Distinction for her Masters in Law (LLM) dissertation. Jeannie is also international Law & Regulatory Fellow of the Washington Democracy Institute.
Dr Courtney is a Cancer Institute New South Wales Early Career Research Fellow at the University of New South Wales (UNSW), National Drug and Alcohol Research Centre and current Margaret Hamilton Award recipient for outstanding research achievement in drug and alcohol research. Dr Courtney’s published work includes research on smoking cessation, in particular tobacco smoking in socially disadvantaged groups. His research has a strong intervention focus and is aimed at reducing the social gradient in smoking cessation. Dr Courtney is an investigator on over $4.8 million in competitive research funding nationally and internationally including the following projects: (i) RCT to test the efficacy of reducing financial stress to increase smoking cessation; (ii) world-first head-to-head RCT of cytisine vs varenicline for smoking cessation; (iii) relapse prevention RCT testing the efficacy of electronic cigarettes; RCT on the cost-effectiveness of technology-based interventions to increase treatment adherence and smoking cessation; (iv) CI on other Category 1 funded grants, including the impact of electronic nicotine device use in youth cohorts.
Luc Van Daele has been vaping since 2007, first as a dual user, but when products became more reliable he switched completely to vaping. Being already aware of the threats of over regulating he has been actively involved in convincing politicians and regulators since the first day he became a vaper. He also played an active part in improving on the first generation of e-cigarettes, sending his designs to Chinese manufacturers who took some of them in production.
Luc was formed as an architect and specialised as an engineer in building acoustics. He started his first company at the age of 25 and enjoyed an international career in Belgium, the UK and France. Now enjoying an early retirement in the south of France, he spends his time on vaping advocacy, designing new vaping products and playing golf.
Donna Darvill comes from a background in Sales and Marketing to the Health, Education and Legal Professions. Although retired due to ill health, she found her new passion in Vaping Advocacy in Australia. A lifelong heavy smoker who had tried all conventional methods to quit, she found herself lighting her last cigarette nearly two years ago thanks to e-cigarettes. Donna is thrilled to be a founding Board Member of the NNA Australia and looks forward to the big job ahead.
Dr Lynne Dawkins is an Associate Professor of Psychology in the Addictions Unit at London South Bank University. She has twenty years’ experience of working with smokers in research contexts and, more recently, with novice and experienced e-cigarette users. Dr Dawkins is one of the UK’s leading authorities on e-cigarettes having published papers on their utilisation, effects, and nicotine delivery. She has disseminated her findings widely via academic conference, public lectures and online media.
Stefan Didak switched from smoking to vaping over 4 years ago and has been a vocal and active supporter and advocate for vapor products and is frequently seen testifying in front of state and local legislators and policy makers.
Outside of Stefan’s legislative and PR efforts, including the creation of the notblowingsmoke.org website and movement and the newnomorecasualties.org educational campaign, he is mostly known for working out of the world’s most famous home office. Prior to dedicating all his time to vaping advocacy he was a software engineer who started his first business at the age of 18 and for over 25 years has been involved in developing 3D computer graphics and animation software.
Miroslaw Dworniczak, PhD - chemist, freelance science journalist, former scientist and lecturer at the Department of Chemistry, Adam Mickiewicz University (Poznan, Poland). Author (under the name "Stary Chemik" - "Old Chemist") of the first blog in Poland dealing with e-cigarettes and e-liquid chemistry and safety (http://starychemik.wordpress.com - in Polish).
J.F. Etter (PhD) has over 20 years of conducting smoking etiology, prevention and cessation research. He has published widely on smoking cessation trials and various psychological questions related to tobacco dependence and smoking cessation. He is an internationally known expert on e-cigarettes. He has recently published a comprehensive book on e-cigarettes. In addition, he is credited with publishing some of the first scientific papers on e-cigarettes. His research has been crucial in shaping the initial understanding of the reasons and patterns of e-cigarette use.
Dr Konstantinos Farsalinos , Onassis Cardiac Surgery Center, Athens, Greece
Dr Konstantinos Farsalinos is a cardiologist, working as researcher at Onassis Cardiac Surgery Center in Athens-Greece and at University of Patras in Greece. His main research interests are new modalities in cardiovascular imaging and he has received a scholarship from the Greek Society of Cardiology for research and education in this field. He has studied the effects of smoking on subclinical cardiac dysfunction using new imaging techniques since 2010.
He has been actively performing research on electronic cigarettes since 2011 as a principle investigator, in both clinical and laboratory level. Examples of his work include the first study on the cytotoxic effects of electronic cigarette vapor on cultured cells and the immediate effects of electronic cigarettes used on cardiac function and coronary circulation. He has presented his research in major international scientific congresses and has published more than 40 studies about e-cigarettes in peer-reviewed medical journals.
Dr Chris Ford recently retired from General Practice in London where she worked for 30 years. During this time she developed a special interest in working with people who use drugs and/or alcohol many with HIV and/or hepatitis. Increasingly concerned about the gap between practice and policy, Chris and others founded a UK network for supporting all health professionals working with people who have drug problems. In 2009 Chris set up International Doctors for Healthier Drug Policies (IDHDP) to be a bridge between practice and policy and to increase the international participation of medical doctors in drug policy and continues as Clinical Director.
Moira Gilchrist works in Regulatory and Scientific Affairs at PMI. Responsible for driving company strategy to transparently and comprehensively communicate PMI’s Reduced Risk Product (RRP) science to stakeholders in the scientific, public health and regulatory communities. She's currently working on tools and techniques to improve access to our science so that relevant stakeholders can make their own judgement on our approach and results. Her works are published in the websites of many different organizations including E-Cig Europe Conference, FDLI Annual Conference or Society for Research on Nicotine and Tobacco. She received her PhD in Pharmaceutical Sciences from the University of Strathclyde.
Joseph (Joe) G. Gitchell serves as President at PinneyAssociates. Joe leads efforts supporting regulatory approvals, conducting public policy analysis, and providing input on strategic market opportunities and directions. He has worked for clients in the US, Europe, Latin America, Asia and the Middle East. This work has included extensive collaboration with researchers and policy experts around the world.
A co-author on over 40 articles, Joe has been published in journals including Tobacco Control, Preventive Medicine, Addiction, Archives of Internal Medicine, and Morbidity and Mortality Weekly Report.
Joe joined PinneyAssociates in 1993 after graduating magna cum laude from Yale University and working on the 1992 U.S. presidential campaign.@jgitchell
After 15 years focused on research, Associate Professor Marewa Glover has recently taken up a teaching role in Massey University's School of Public Health. Her primary focus for her teaching and research will continue to be tobacco control, particularly reducing tobacco smoking while pregnant and reducing Māori smoking. She is a co-investigator on a number of innovative cessation projects and a longitudinal online survey of New Zealand vapers.
Dr Glover is Chair of End Smoking NZ, and an Associate Member of the New Nicotine Alliance UK and the New Nicotine Alliance Australia. She is a leading proponent in New Zealand for a just and honest response to the growth in vaping and the vaping community. The import and sale or distribution of nicotine eliquid is banned in NZ. To assist low income and internet deprived smokers' who wanted to vape instead of smoking, Marewa set up Vape It Forward on Twitter. @vapeitfwd allows overseas people to donate and send starter kits and nicotine eliquid direct to smokers in NZ.
Gillian Eva Golden comes from a background in the creative, customer service, and retail sectors. A former smoker thanks to discovering vaping in 2012, she now works as administrator for the Irish Vape Vendors Association, Ireland's only trade association for independently owned, specialised retailers of vaping products. She not only advocates for vaping as a means of tobacco harm reduction, but also for industry stewardship, and sits on the Technical Committee of CEN TC 437 for electronic cigarettes and e-liquids.
Dr. Amy Faith Ho is a emergency physician in the US. She holds multiple national leadership positions in American medical organizations like the American Medical Association, Illinois State Medical Society, American Academy of Emergency Medicine and Illinois College of Emergency Physicians. She is published largely on healthcare in forums like NPR, Forbes, Chicago Tribune, KevinMD and others, including several pieces focused on mental health. Her interest in addiction stemmed from her time interning at the renowned Betty Ford Center and again in the emergency room where substance and tobacco abuse is commonplace. Dr. Ho is also a seasoned speaker, with media engagements include presentations with TEDx, National Public Radio and the Discovery Channel.
In 2012 Amelia Howard bought a cigarette-shaped battery and cartridge filled with a nicotine solution that she tried and failed to quit smoking with. Confused as to whether this was because she was doing something wrong, if she'd bought an inferior product, or if the technology was altogether flawed, she started researching electronic cigarettes on the Internet, and never really stopped. She did stop smoking.
As a PhD candidate in sociology at the University of Waterloo, she's writing a dissertation about the role of the Internet in facilitating vaping innovation and practice, and the political controversy over vaping technologies.
Martin Jarvis is Emeritus Professor of Health Psychology at the Department of Epidemiology and Public Health, University College London. Over the past 35 years he has researched and published widely on tobacco smoking, with special interests in the role of nicotine, social and family influences on smoking, smoking cessation methods and passive smoking. He is a trustee of ASH, and was Deputy Chair of the UK government’s Scientific Committee on Tobacco and Health and Specialist Adviser to the House of Commons Health Committee’s inquiries into tobacco and health and into smoking in public places. He was awarded an OBE in 2002 and was given the John Slade award of the Society for Research on Nicotine and Tobacco in 2008.
Since leaving school 'a very long time ago' Sarah Jakes has worked in the shipping industry, the foreign exchange market and now runs her own business in property management. A smoker of some 35 years Sarah switched to vaping in April 2013, only to find that the choice of this safer alternative for smokers was under threat from excessive and ill founded regulation. Having joined forces with other consumers in the battle against over regulation in the EU parliament Sarah is convinced that a better understanding of e-cigarettes and other harm reduced products among key influencers and decision makers is required if these products are ever to reach their full potential for public health gains.
Lorien Jollye is a mother of 3, an ex smoker of 23 years and a Vaper since 2012. After numerous, unsuccessful, quit attempts utilising most all the market had to offer, and smoking through two pregnancies, she found that e-cigarettes enabled her to switch her habit entirely, in one day. Since then, she has been a vocal advocate, volunteering with the Consumer Association and latterly, The New Nicotine Alliance, along with other passionate vapers. It has become a simple message, Nothing About Us Without Us.
Cecilia Kindstrand is Director of Public Affairs for Swedish Match, a tobacco company with tobacco harm reduction at the core of its business. She is based in Brussels and has worked extensively with the revision of the EU’s Tobacco Products Directive, a legislation banning the ‘proof of concept’ of tobacco harm reduction in 27 of the 28 Member States. The vision of Swedish Match is A World Without Cigarettes.
Patricia I. Kovacevic, Esq. is the General Counsel and Chief Compliance Officer of Nicopure Labs LLC. With extensive U.S. and international industry experience, Ms. Kovacevic held senior legal and compliance positions at, among other, Philip Morris International and Lorillard. Prior to joining Lorillard she was a partner at Patton Boggs. Her expertise includes global e-cigarette and tobacco regulation, compliance and all regulatory aspects of marketing/media communications, corporate affairs, criminal investigations, FCPA, trade sanctions, privacy, product development and launch. Ms. Kovacevic serves on the advisory board of the Global Tobacco and Nicotine Forum and on the board of the Vapor Technology Association, where Nicopure Labs is a founding member. In the past she was a United Nations staff member, served on UN's Public-Private Partnership Commission and was also an advisor to the Council for Burley Tobacco. Ms. Kovacevic is admitted to practice in New York and before the Supreme Court of the United States. She holds a Juris Doctor degree from Columbia Law School (NY) and has completed the Harvard Business School “Corporate Leader” management course. She is fluent in seven European languages. @patriciakova
Dr. Bethea (Annie) Kleykamp is a Scientist at the health-care consulting firm, PinneyAssociates. She earned her PhD at Virginia Commonwealth University and completed postdoctoral training at the Johns Hopkins University School of Medicine and the Intramural Program of the National Institute on Drug Abuse. Her research focused on the cognitive effects of a variety of psychoactive drugs (e.g., nicotine, alcohol, methadone). Prior to joining PinneyAssociates in 2014, she worked at the health technology assessment company, Hayes, Inc., where she wrote systematic reviews that informed healthcare decisions for government, health insurance, and healthcare provider clients. Currently her responsibilities at PinneyAssociates include conducting literature reviews, interpreting and synthesizing data, and applying her writing skills across a variety of content areas (e.g., tobacco harm minimization, prescription to over-the-counter switch, risk management).
Scott J. Leischow, Ph.D. joined the Mayo Clinic in 2012, where he leads the Research on Health Equity and Community Health (REACH) Program at Mayo Clinic Arizona, and co-leads Cancer Prevention and Control within the Mayo Clinic Cancer Center. He was formerly University of Arizona and also served as Senior Advisor for Tobacco Policy in the US Department of Health and Human Services and Chief of the Tobacco Control Research Branch at the National Cancer Institute of NIH. Dr. Leischow completed his doctorate in Health Education from the University of Maryland, and a postdoctoral fellowship in Behavioral Pharmacology from Johns Hopkins University. Dr. Leischow has received several awards, including the NIH Director’s Award. Most of Dr. Leischow’s research and publications focus on pharmacologic and behavioral treatments for tobacco dependence, along with systems and network approaches to public health. Dr. Leischow is past President of the Society for Research on Nicotine and Tobacco (SRNT).
Karl Lund, Research Director of the Department of Alcohol, Drug and Tobacco Research at the Norwegian Institute for Public Health. He has been involved in tobacco control work since the mid 1980s, working at the Norwegian Council on Tobacco or Health (Deputy Leader), the Norwegian Cancer Society (Director for Department of Cancer Prevention) and Norwegian Institute for Alcohol and Drug Research (Research Director). Dr. Lund received the Norwegian Medical Association’s Award in preventive medicine in 2002. He is well published within tobacco research, has been a lecturer on tobacco topics in several countries worldwide, and has been a member of several expert committees on tobacco control including WHO’s International Agency for Cancer Research (IARC). He has been an expert witness in several court cases against the tobacco industry in Norway. Dr. Lund has been Associate Editor in the scientific journal Nicotine & Tobacco Research since 2011 and Senior Associate Editor of Tobacco Regulatory Science since 2015.
Dainius Martuzevicius is an Associate Professor at the Department of Environmental Technology, Faculty of Chemical Technology, Kaunas University of Technology. He teaches courses on air quality management, modeling, and pollution control technologies. He also serves as a Vice Dean for Research at the Faculty of Chemical Technology. The background on the research of air quality and aerosols was obtained during his stay as a visiting scientist in the Center of Health-Related Aerosol Studies at the University of Cincinnati, Ohio, during 2002-2005. His research interests include measures for the improvement of indoor and outdoor air quality. Recently, he has coordinated Lithuanian actions in several major European and national research projects. He applies interdisciplinary knowledge on aerosols and air quality to solving of the microclimate issues in public and residential, low-energy and green buildings.
Anastasia Moysidou is a registered nurse, graduate of the Nursing Department of the Technological Educational Institute of Athens (1998 -2002). She has specialized in internal medicine and has worked at the Department of Internal Medicine of the General Hospital of Kastoria, at the Oncological Hospital “Agioi Anargiroi” in Athens and at the Urological Department of the Metaxas Hospital in Piraeus. She currently works at a primary healthcare center in Athens. She obtained her Master of Public Health degree from the National School of Public Health in Athens in 2015. Her main focus of research during the course was smoking and smoking alternatives, including nicotine-containing products such as electronic cigarettes. She has also participated in educational campaigns in schools about smoking. She was the principle investigator in a study evaluating knowledge and perceptions of healthcare professionals in Greece about smoking, nicotine and electronic cigarettes.
Neil McKeganey is the founding director of the Centre for Drug Misuse Research at the University of Glasgow which he directed from 1994 to 2011. He now runs the Centre as an independent research group undertaking studies in a wide range of areas related to the use of illegal drugs drugs. – www.drugmisuseresearch.org – He has written over 150 academic articles and is the author of “Controversies in Drugs Policy and Practice” (Palgrave 2011). He is a sociologist by training and has undertaken research himself in such areas as the evaluation of drug treatment services, the nature and impact of drug policy, young people and illegal drugs, the impact of parental drug use on children, the link between drugs, crime and prosittution and the impact of drug enforcement activities.
Professor Ann McNeill is a British academic and tobacco policy expert. She is currently a Professor of Tobacco Addiction in the National Addictions Centre at the King's College London Institute of Psychiatry, Psychology & Neuroscience and Deputy Director of the UK Centre for Tobacco and Alcohol Studies.
McNeill has devoted her career to reducing the harmfulness of smoking to individuals and society and has worked in prevention, cessation and harm reduction, in particular how to reduce the health inequalities caused by smoking. McNeill is a Council member of Action on Smoking and Health and is a trustee of the Society for the Study of Addiction and of Tobacco Free Futures.
Dr Colin Mendelsohn is a medical practitioner and tobacco treatment specialist in private practice in Sydney, Australia. He provides inpatient smoking cessation services at a psychiatric hospital as well as community-based consultations. He is actively involved in teaching health professionals, writing, research (reluctantly), public education and consulting to industry. Colin is a member of the committee that develops the Australian national smoking cessation guidelines and is the immediate past Vice President of the Australian Association of Smoking Cessation Professionals. He teaches at the University of Sydney and regularly conducts workshops and lectures for health professionals around Australia. He is on the steering committee developing QUIT4october, an Australian national smoking cessation campaign.
Stefanie Miller is an investment analyst covering the tobacco industry at Height Securities, an investment research advisor and a regulated broker-dealer based in Washington, DC that specializes in coverage of heavily regulated industries. Stefanie’s work at Height Securities includes non-securities related services to corporate clients, including Philip Morris International. Stefanie previously worked at McBee Strategic Consulting where she was an analyst in the firm’s investment research group and a Vice President in the company’s public relations practice. She has also worked as a political fundraiser. Stefanie has an MBA from the Georgetown University McDonough School of Business, and a BA in Economics and Political Science from the University of Nebraska.
Julian Morris is Vice President of Research at Reason Foundation, a non-profit, non-partisan think tank in the U.S. Trained in economics and law, Julian has written extensively on innovation, the regulation of risk, and the role of international agreements. In addition to his role at Reason, Julian is a Senior Fellow at the International Center for Law and Economics and a Fellow of the Royal Society of Arts. Prior to joining Reason, Julian ran International Policy Network, an international think tank. He was also a Visiting Professor in the Department of International Studies at the University of Buckingham and a member of the Council of the School of Pharmacy. Before that he ran the environment and technology program at the Institute of Economic Affairs in London.
Marcus Navin-Jones specialises in EU Litigation and EU Regulatory law. He is a solicitor-advocate with the Law Society of England and Wales, a qualified mediator with the CEDR London, and a member of the Belgian Centre for Arbitration and Mediation (CEPANI). He is the current secretary and founder of the EU Chemicals Board of Appeal Forum. Mr. Navin-Jones has extensive experience of mounting appeals before the ECHA Board of Appeal.
Barnaby Page, EcigIntelligence, UK
Barnaby Page is a journalist with 30 years’ experience including roles at Media Week, aka.tv, TechWeb.com, and Casino International; he has been a reporter and editor on numerous magazines and broadsheet newspapers in Britain, Canada and the Middle East, specialising in business, technology/innovation, marketing and regulation. Since its launch in 2014 Barnaby has led the editorial team at ECigIntelligence, covering e-cigarette regulation, industry news and science around the world.
Sudhanshu Patwardhan is a medical doctor and an MBA with nearly two decades of international experience in biomedical research and regulatory strategy in the pharmaceutical and tobacco industries. He has worked in the British American Tobacco Group for the past ten years, focusing on tobacco harm reduction science, policy and regulation. He strongly believes that globally accepted quality and safety standards for vapour products are key to assuring regulators and also inspiring consumer confidence to switch out of smoking. Following his work in the BSI steering group to create the world’s first quality and safety specifications for vapour products, he is now a Co-convenor at the European CEN working group on definitions and terminology related to vapour products.
Sud lives in Hampshire, England with his wife and two children. He is passionate about Indian music and is very active as a Director of the charity Art Asia, UK.
Remi Parola works as a coordinator of FIVAPE (Fédération Interprofessionnelle de la VAPE). He has expertise in project management and public policy. He studied International and European Law at Université Paris Sud and at Université libre de Bruxelles.
Prof Riccardo Polosa is a director of the Institute for Internal and Emergency Medicine of the University of Catania in Italy. He is also in charge of the University's Centre for Tobacco Research (CPCT), and Honorary Professor of Medicine at Southampton University (UK). He is author of more than 250 peer reviewed articles and books mainly covering respiratory medicine, clinical immunology, and tobacco addiction.
On top of his academic work, he serves also as chief scientific advisor for Lega Italiana Anti Fumo (LIAF), the Italian Anti-Smoking League. Prof Polosa's and his research team have lead several clinical trials on e-cigarettes, for whose expertise he has been recently elected Convenor for the European Working Group on “Requirements and test methods for emissions of electronic cigarettes”, within the European Committee for Standardization (CEN/TC 437).
Dr. Taman Powell is the Founder & CEO of XOLO (xolovape.com), a company that has developed a product aimed at solving the most pressing problem in vaping today: how to achieve a high-performance vape without the hassle.
The company was started from the belief that current products force consumers to choose between ease of use OR high performance. The aim of XOLO is to bring vaping to the smoking/non-vaper mass market via providing a beautiful, simple to use device that also delivers a high performance vaping experience.
Chris Proctor is British American Tobacco’s Chief Scientific Officer and Group Head of Scientific Product Stewardship, working at Research and Development in Southampton, UK. He is a PhD chemist with postdoctoral research experience at Cornell University, under a Fulbright scholarship, and the University of Kent. Chris joined BAT in 1983, working in research and development on analytical chemistry. In 1990 Chris left BAT to work as a senior scientific advisor to a law firm in Washington DC, before returning to BAT in 1993. Chris has represented BAT in public hearings on the World Health Organisation’s Framework Convention on Tobacco Control and in front of the WHO’s Study Group on Tobacco Product Regulation, has chaired two steering groups of the European Policy Centre on the use of science in regulatory decision making and better regulation, has recently presented at a scientific expert at US FDA workshops, and is a member of the American Chemical Society’s Corporation Associates.
In 2003 Chris published “Sometimes a cigarette is just a cigarette”, a book exploring the historic efforts of tobacco companies, research scientists and the public health community to encourage less risky tobacco products.
Tom Pruen is Chief Scientific Officer at ECITA. He received his BSc degree in Applied Chemical Science from the University of the West of England. He has expertise in project management and information technology.
Louise Ross is the Stop Smoking service manager for Leicester City, working for Leicester City Council while maintaining strong links with all NHS bodies in the area. She has worked in smoking cessation and tobacco control for over ten years. Previously she had managed a large care home for people with learning disabilities for almost 30 years, and this career change, an opportunity that disproves the theory that one needs a life-plan to be happy, has been a fantastic opportunity to influence people’s health for the better.
Initially suspicious of e-cigs, since 2013 she became a committed advocate of listening to what the general public, and Stop Smoking service users in particular, are saying about their experiences of vaping.
Dr Christopher Russell is a psychologist working at the Centre for Drug Misuse Research, Glasgow, Scotland. Dr Russell has developed a significant number of studies in the area of nicotine science over the last two years including research on users’ early experiences of e-cigarettes and perceived health risks and benefits, modelling the effect of e-cigarettes on the health of smoking and non-smoking sub-populations, modelling the chronology of smoking and vaping initiation and quitting, systematic reviews of the health effects of co-occurring tobacco and cannabis smoking, and research assessing the evidence for the effectiveness of plain tobacco packaging in Australia. Dr Russell has also developed a ‘Nicotine Science Toolbox’, an online ‘library’ that provides researchers with guided access to a wide range of survey and questionnaire instruments for measuring cognitive and behavioural constructs known to influence individuals’ decisions to start, stop and restart smoking and vaping.
Prof . Andrzej Sobczak, head of the Department of General and Inorganic Chemistry at Medical University of Silesia and head of the Department of Chemical Hazards and Genetic Toxicology at the Institute of Occupational Medicine and Environmental Health in Sosnowiec in Poland. Prof. Sobczak has been focusing on the toxicology of tobacco smoke for many years. Growing popularity of e-cigarettes led him to investigate these devices.
Michal Stoklosa is a Senior Economist, Taxation & Health within the Economic and Health Policy Research Program at the American Cancer Society. Michal’s research focuses primarily on topics related to economics of tobacco control such as tax policies, illicit cigarette trade, and the tobacco industry’s strategies to undermine tobacco control efforts. As economic arguments have become increasingly important to the formulation of health policies, Michal’s research projects aim to provide governments and health advocates with credible economic evidence to support health policy change. His time with the American Cancer Society has led to opportunities of sharing his research findings with policy makers, such as testifying before Budgetary Control Committee of the European Parliament. His most recent research interests include the taxation of electronic cigarettes.